Comparative Immunoreactivity of iNOS , PCNA and p53 in Stable and Progressive Canine Transmissible Venereal Tumours
Veterinary and Comparative Oncology · 08.11.2026
DOI: 10.1111/vco.70120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 08.11.2026. Verfasst von Gungor Cagdas Dincel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pathology, Faculty of Medicine, Ankara Medipol University, Ankara, Türkiye. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
Canine transmissible venereal tumour (CTVT) is a naturally occurring transmissible neoplasm with variable biological behaviour, including progressive growth, stationary behaviour and spontaneous regression. However, the marker‐expression patterns associated with these clinicopathological phenotypes remain incompletely characterised. The present study investigated iNOS, PCNA and p53 expression in CTVT and evaluated their association with the operational clinicopathological phenotype. Sixteen genital CTVT samples obtained from surgically treated dogs were classified as stable ( n = 7) or progressive ( n = 9) using predefined criteria requiring concordance between local invasion and quantitative mitotic count. Immunohistochemistry was performed for iNOS, PCNA, p53 and cytokeratin (CK), and immunoreactivity was evaluated semiquantitatively by two blinded observers. Progressive tumours showed significantly higher iNOS, PCNA and p53 immunoreactivity scores than stable tumours. Across the three markers, median scores ranged from 0 to 1 in stable tumours and were 3 in progressive tumours, with significant differences in all comparisons (Mann–Whitney U = 0.0; two‐sided exact p = 0.0002). iNOS immunoreactivity was predominantly cytoplasmic in tumour cells, with occasional staining in vascular endothelial and inflammatory cells, whereas PCNA and p53 showed widespread nuclear positivity in progressive tumours and more limited expression in stable tumours. CK immunoreactivity was absent in all samples, consistent with the absence of detectable cytokeratin expression in the examined tumours. To our knowledge, the present study provides the first tumour‐cell‐focused characterisation of iNOS immunoreactivity in CTVT, evaluated concurrently with PCNA and p53 across operationally defined stable and progressive clinicopathological phenotypes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Pathology, Faculty of Medicine, Ankara Medipol University, Ankara, Türkiye.
- Department of Pathology, Faculty of Veterinary Medicine, University of Atatürk, Erzurum, Türkiye.
- Department of Pathology, Faculty of Veterinary Medicine, Kyrgyz-Turkish Manas University, Chingiz Aitmatov Campus, Djal, Bishkek, Kyrgyzstan.
- Department of Pathology, Faculty of Veterinary Medicine, University of Kırıkkale, Kırıkkale, Türkiye.
- Department of Pathology, Faculty of Veterinary Medicine, University of Balikesir, Balıkesir, Türkiye.
- Department of Surgery, Faculty of Veterinary Medicine, University of Van Yuzuncu Yil, Van, Türkiye.
ORCID-Profile: Gungor Cagdas Dincel, Saeed El-Ashram
Zitieren
APA
Dincel, G. C., Yıldırım, S., Anteplioğlu, T., İlhan, F., Karasu, A., Cetin, N., AlOlayan, E., & El-Ashram, S. (2026). Comparative Immunoreactivity of iNOS , PCNA and p53 in Stable and Progressive Canine Transmissible Venereal Tumours. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.70120
Vancouver
Dincel GC, Yıldırım S, Anteplioğlu T, İlhan F, Karasu A, Cetin N, et al. Comparative Immunoreactivity of iNOS , PCNA and p53 in Stable and Progressive Canine Transmissible Venereal Tumours. Veterinary and Comparative Oncology. 2026. doi:10.1111/vco.70120
BibTeX
@article{Dincel2026,
author = {Dincel, Gungor Cagdas and Yıldırım, Serkan and Anteplioğlu, Tuğçe and İlhan, Fatma and Karasu, Abdullah and Cetin, Nebi and AlOlayan, Ebtesam and El-Ashram, Saeed},
title = {Comparative Immunoreactivity of iNOS , PCNA and p53 in Stable and Progressive Canine Transmissible Venereal Tumours},
journal = {Veterinary and Comparative Oncology},
year = {2026},
doi = {10.1111/vco.70120}
}
EUVIMED